Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-61.12	817.77	2103.17
Graham Fair Price	-79.84	290.77	1442.44
PEG	-11541.29	-29.93	-0.26
Price/Book	-52.12	8.42	17.58
Price/Cash Flow	-87.61	487.15	-3931.65
Prices/Earnings	1093.16	3113.99	-260.99
Price/Sales	-45.80	35.09	64.75
Price/FCF	-87.61	487.15	-3931.65
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	24.40	0.10	0.08
Operating Margin	60.25	0.03	0.02
ROA	-95.84	< 0.005	-0.01
ROE	-0.02	< 0.005	-95.99
ROIC	< 0.005	< 0.005	42.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.23	0.32	-27.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.82	0.42	-84.96
EPS QOQ	-10.15	1.04	-89.75
FCF QOQ	-1.17	4.89	316.31
Revenue QOQ	0.06	-0.11	84.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.40	38.73	9.41
Days Sales Outstanding (DSO)	79.23	77.59	-2.06
Inventory Turnover	2.54	2.32	-8.60
Debt/Capitalization	0.09	0.07	-21.80
Quick Ratio	1.57	1.79	13.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2343.11	2357.92	0.63
Cash	510.34	487.86	-4.41
Capex	-4.17	-3.79	9.09
Free Cash Flow	-10.48	40.75	288.84
Revenue	636.30	565.63	-11.11
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.93	2.22	14.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.40	-12.98	9.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating